What is the CVR number of CiVi Biopharma ApS?

CiVi Biopharma ApS is registered with CVR / Virk under CVR 38027794.

What is the revenue of CiVi Biopharma ApS?

CiVi Biopharma ApS reported revenue of DKK 611K in 2024.

How many employees does CiVi Biopharma ApS have?

CiVi Biopharma ApS employs 1 people as of the latest annual report.

Who is the CEO of CiVi Biopharma ApS?

Signe Melhedegård Hansen is Unofficial title of CiVi Biopharma ApS, in role since 2025.

Who is the chairman of CiVi Biopharma ApS?

Martin Lavesen chairs the board of CiVi Biopharma ApS, in role since 2016.

Where is CiVi Biopharma ApS headquartered?

CiVi Biopharma ApS's registered address is Sundkrogsgade 21.

CiVi Biopharma ApS

APSIn liquidation

CVR 38027794Sundkrogsgade 21Research and experimental development on natural sciences and engineering · NACE 7210Est. 20161 employees

Full Risika report

Revenue 2024

DKK 611K

-83% vs 2023

EBITDA margin

-239.9%

-465% vs 2023

Equity ratio

60.9%

Financial strength

Net profit 2024

DKK -1,4M

+25% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK 611K	-83%
EBITDA	DKK -1,5M	-465%
Net profit	DKK -1,4M	+25%
Total assets	DKK 128K	-94%
Equity	DKK 78K	-95%
Employees	1	—

Item	2020	2021	2022	2023	2024
Revenue	4.485	4.036	3.530	3.502	611
Staff expenses	-3.970	-3.583	-3.100	-3.100	-2.075
EBITDA	515	453	430	402	-1.465
Depreciation & amort.	-0	-0	-0	-0	-0
EBIT	515	453	430	402	-1.465
Net financials	-12	-11	-11	-2.200	80
Profit before tax	503	442	419	-1.798	-1.385
Tax	111	98	93	89	26
Net profit	392	344	326	-1.887	-1.410

Item	2020	2021	2022	2023	2024
Total assets	4.114	4.332	3.948	2.285	128
Equity	2.705	3.049	3.375	1.488	78
Long-term debt	0	0	0	0	0
Short-term debt	1.409	1.283	572	797	50
Total debt	1.409	1.283	572	797	50

Name	Role	Member since
Former (2)
SM Signe Melhedegård Hansen Unofficial title	Unofficial title	2025 – 2026
HØ Henrik Ørum Chief Executive Officer	Chief Executive Officer	2016 – 2024

Name	Role	Member since
Former (1)
ML Martin Lavesen	Chairman	2016 – 2024

Shareholder	Type	Ownership	Votes	Since
CiVi Biopharma, Inc.	Individual	100%	100%	2018
Jess Thiersen	Individual	100%	100%	2016
RINC Biotech, Inc.	Individual	100%	100%	2016

Person	Role here	Other companies
Signe Melhedegård Hansen	Unofficial title	0 companies
Henrik Ørum	Chief Executive Officer	0 companies
Martin Lavesen	Chairman	0 companies